Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 23 EP applications Luc Quaghebeur has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11707172

IMIDAZO [1, 2 -A]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES

IPC classification:
A61K 31/4985, A61P 3/00, A61P 25/00, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP11804561

5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61K 31/5025, A61P 25/00, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP12707276

6,7-DIHYDRO-PYRAZOLO[1,5-A]PYRAZIN-4-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61K 31/4985, A61P 25/28, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12707319

3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61K 31/4985, A61K 31/506, A61P 25/28, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12794731

6-DIFLUOROMETHYL-5,6-DIHYDRO-2H-[1,4]OXAZIN-3-AMINE DERIVATIVES

IPC classification:
A61K 31/5377, A61P 25/16, A61P 25/28, C07D 413/10, C07D 413/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12794730

5-(3-AMINOPHENYL)-5-ALKYL-5,6-DIHYDRO-2H-[1,4]OXAZIN-3-AMINE DERIVATIVES

IPC classification:
A61K 31/5377, A61P 25/00, C07D 265/30, C07D 413/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11729962

3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATEMENT OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA

IPC classification:
A61K 31/495, A61P 25/28, C07D 241/08, C07D 401/10, C07D 401/12, C07D 403/10
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14701007

NOVEL SUBSTITUTED PYRIDO-PIPERAZINONE DERIVATIVES AS GAMMA SECRETASE MODULATORS

IPC classification:
A61K 31/498, A61P 25/28, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP13814535

NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS

IPC classification:
A61K 31/4985, A61P 25/28, C07D 471/14
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP11784506

ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-A][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-A][1,4]BENZODIAZEPINES SUBSTITUTED WITH PHENYL DERIVATIVES

IPC classification:
A61K 31/5517, A61P 31/10, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11748693

5-HT2B RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4468, A61P 11/00, C07D 211/58
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11757886

4,7-Dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta secretase (BACE)

IPC classification:
A61K 31/4985, A61P 25/28, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11781524

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/10, A61K 9/20, A61K 31/5377, A61K 31/542, A61K 45/06, A61P 25/18, C07D 471/02, C07D 471/04
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723091

5-Amino-3,6-dihydro-1H-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (BACE)

IPC classification:
A61K 31/496, A61P 25/16, A61P 25/28, C07D 401/10, C07D 401/12, C07D 403/10
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723445

NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUORETHYL)PHENYL]-4H-PYRROLO[1,2-A][1,4]BENZODIAZEPAN AND 4-(DIFLUORETHYL)PHENYL-6H-PYRROLO[1,2-A][1,4]BENZODIAZEPIN DERIVATIVES.

IPC classification:
A61K 31/5517, A61P 31/10, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11802072

NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES

IPC classification:
A61K 31/5517, A61P 31/10, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779667

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/20, A61K 31/437, A61K 31/4545, A61K 31/496, A61K 31/498, A61K 31/5377, A61K 31/542, A61K 45/06, A61K 47/06, A61K 47/10, A61K 47/26, A61K 47/38, A61P 25/18, C07D 471/02, C07D 471/04
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11781523

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/20, A61K 31/437, A61K 31/542, A61K 45/06, A61P 25/18, C07D 471/02, C07D 471/04
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723974

5,6-DIHYDRO-2H-[1,4]OXAZIN-3-YL-AMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61K 31/535, A61K 31/5355, A61P 25/16, A61P 25/28, C07D 265/30, C07D 413/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP15804426

RADIOLABELLED MGLUR2 PET LIGANDS

IPC classification:
A61K 51/04, A61P 25/18, A61P 25/24
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15802148

6,7-DIHYDROPYRAZOLO[1,5- ]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 31/4985, A61P 25/00, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15807918

1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 31/437, A61P 25/00, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15820456

2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE AND 3,4-DIHYDRO-2H-PYRROL-5-AMINE COMPOUND INHIBITORS OF BETA-SECRETASE

IPC classification:
A61K 31/506, A61P 25/28, C07D 401/10, C07D 401/12, C07D 403/10, C07D 403/12, C07D 413/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
Request for examination was made

Please Sign in to use this feature